Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cocaine Inhibits Dopamine D2 Receptor Signaling via Sigma-1-D2 Receptor Heteromers
Gemma Navarro, Estefanía Moreno, Jordi Bonaventura, et al.
PLoS ONE (2013) Vol. 8, Iss. 4, pp. e61245-e61245
Open Access | Times Cited: 127

Showing 1-25 of 127 citing articles:

The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems
Tsung‐Ping Su, Tzu-Chieh Su, Yoki Nakamura, et al.
Trends in Pharmacological Sciences (2016) Vol. 37, Iss. 4, pp. 262-278
Open Access | Times Cited: 273
Neuronal Sigma-1 Receptors: Signaling Functions and Protective Roles in Neurodegenerative Diseases
Daniel A. Ryskamp, Svetlana A. Korban, Vladimir Zhemkov, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 169
Developmental origins of brain disorders: roles for dopamine
Kelli M. Money, Gregg D. Stanwood
Frontiers in Cellular Neuroscience (2013) Vol. 7
Open Access | Times Cited: 193
Potential applications for sigma receptor ligands in cancer diagnosis and therapy
Aren van Waarde, Anna A. Rybczynska, Nisha K. Ramakrishnan, et al.
Biochimica et Biophysica Acta (BBA) - Biomembranes (2014) Vol. 1848, Iss. 10, pp. 2703-2714
Open Access | Times Cited: 149
The Molecular Function of σ Receptors: Past, Present, and Future
Hayden R. Schmidt, Andrew C. Kruse
Trends in Pharmacological Sciences (2019) Vol. 40, Iss. 9, pp. 636-654
Open Access | Times Cited: 144
Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation
Marco Peviani, Eleonora Salvaneschi, Leonardo Bontempi, et al.
Neurobiology of Disease (2013) Vol. 62, pp. 218-232
Closed Access | Times Cited: 117
Functional Selectivity of Allosteric Interactions within G Protein–Coupled Receptor Oligomers: The Dopamine D1-D3 Receptor Heterotetramer
Xavier Guitart, Gemma Navarro, Estefanía Moreno, et al.
Molecular Pharmacology (2014) Vol. 86, Iss. 4, pp. 417-429
Open Access | Times Cited: 116
Understanding the Role of GPCR Heteroreceptor Complexes in Modulating the Brain Networks in Health and Disease
Dasiel O. Borroto‐Escuela, Jens Carlsson, Patricia Ambrogini, et al.
Frontiers in Cellular Neuroscience (2017) Vol. 11
Open Access | Times Cited: 116
Sigma receptors [σRs]: biology in normal and diseased states
Colin G. Rousseaux, Stephanie F. Greene
Journal of Receptors and Signal Transduction (2015), pp. 1-62
Open Access | Times Cited: 113
The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission
Danielle Sambo, Min Lin, Anthony Owens, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 102
Sigmar1’s Molecular, Cellular, and Biological Functions in Regulating Cellular Pathophysiology
Richa Aishwarya, Chowdhury S. Abdullah, Mahboob Morshed, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 74
Clozapine’s multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia
Andrea de Bartolomeis, Licia Vellucci, Annarita Barone, et al.
Pharmacology & Therapeutics (2022) Vol. 236, pp. 108236-108236
Open Access | Times Cited: 48
The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats
Weimin Hong, Hideaki Yano, Takato Hiranita, et al.
Journal of Biological Chemistry (2017) Vol. 292, Iss. 27, pp. 11250-11261
Open Access | Times Cited: 71
Orexin–Corticotropin-Releasing Factor Receptor Heteromers in the Ventral Tegmental Area as Targets for Cocaine
Gemma Navarro, César Quiroz, David Moreno‐Delgado, et al.
Journal of Neuroscience (2015) Vol. 35, Iss. 17, pp. 6639-6653
Open Access | Times Cited: 69
Cocaine Disrupts Histamine H3Receptor Modulation of Dopamine D1Receptor Signaling: σ1-D1-H3Receptor Complexes as Key Targets for Reducing Cocaine's Effects
Estefanía Moreno, David Moreno‐Delgado, Gemma Navarro, et al.
Journal of Neuroscience (2014) Vol. 34, Iss. 10, pp. 3545-3558
Open Access | Times Cited: 69
Mitigation of cocaine-mediated mitochondrial damage, defective mitophagy and microglial activation by superoxide dismutase mimetics
Annadurai Thangaraj, Palsamy Periyasamy, Ming‐Lei Guo, et al.
Autophagy (2019) Vol. 16, Iss. 2, pp. 289-312
Open Access | Times Cited: 67
The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction
Danielle Sambo, Joseph J. Lebowitz, Habibeh Khoshbouei
Pharmacology & Therapeutics (2018) Vol. 186, pp. 152-167
Open Access | Times Cited: 65
AF710B, a Novel M1/σ1 Agonist with Therapeutic Efficacy in Animal Models of Alzheimer's Disease
Abraham Fisher, Ilya Bezprozvanny, Lili Wu, et al.
Neurodegenerative Diseases (2015) Vol. 16, Iss. 1-2, pp. 95-110
Open Access | Times Cited: 64
Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases
Na Ye, Wangzhi Qin, Sheng Tian, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 24, pp. 15187-15217
Closed Access | Times Cited: 63
2016 Philip S. Portoghese Medicinal Chemistry Lectureship: Designing Bivalent or Bitopic Molecules for G-Protein Coupled Receptors. The Whole Is Greater Than the Sum of Its Parts
Amy Hauck Newman, Francisco O. Battiti, Alessandro Bonifazi
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 5, pp. 1779-1797
Open Access | Times Cited: 62
Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders
Kinga Sałaciak, Karolina Pytka
Neuroscience & Biobehavioral Reviews (2021) Vol. 132, pp. 1114-1136
Open Access | Times Cited: 47
Sigma-1 Receptor Signaling: In Search of New Therapeutic Alternatives for Cardiovascular and Renal Diseases
Francisco Javier Munguía-Galaviz, Alejandra Guillermina Miranda‐Díaz, Miguel Alejandro Cardenas-Sosa, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1997-1997
Open Access | Times Cited: 21
The sigma-1 receptor: a regulator of cancer cell electrical plasticity?
David Crottès, Hélène Guizouarn, Patrick Martin, et al.
Frontiers in Physiology (2013) Vol. 4
Open Access | Times Cited: 62
Protection by sigma-1 receptor agonists is synergic with donepezil, but not with memantine, in a mouse model of amyloid-induced memory impairments
Tangui Maurice
Behavioural Brain Research (2015) Vol. 296, pp. 270-278
Closed Access | Times Cited: 58
Cocaine self-administration specifically increases A2AR-D2R and D2R-sigma1R heteroreceptor complexes in the rat nucleus accumbens shell. Relevance for cocaine use disorder
Dasiel O. Borroto‐Escuela, Manuel Narváez, Karolina Wydra, et al.
Pharmacology Biochemistry and Behavior (2017) Vol. 155, pp. 24-31
Closed Access | Times Cited: 56
Page 1 - Next Page

Scroll to top